Dr. Boyan Litchev is President and Chief Medical Executive of Axiavita LLC and an experienced oncology drug developer. He previously served as Chief Medical Officer of Indaptus Therapeutics, led global oncology clinical development at Shoreline Biosciences and solid-tumor CAR-T programs at Poseida Therapeutics. Earlier, he held senior medical roles at Halozyme, Akcea, Baxalta/Shire, Ferring and Quintiles. He earned his MD from Medical University Plovdiv in Bulgaria.
Celebrating Health • HEALTHCARE
REIMAGINED
© 2026 TALHospitals HealthFest. All rights reserved.